Ioannis V. Kostopoulos's 56 research works in Engineering and Economics
Biomedicines | Free Full-Text | Comparison of Neutralizing Antibody Responses at 6 Months Post Vaccination with BNT162b2 and AZD1222
Yannis Gavriatopoulos - Project Owner - Medtronic Diabetes Shop in Athens | LinkedIn
Yannis Gavriatopoulos - Project Owner - Medtronic Diabetes Shop in Athens | LinkedIn
ΙΩΑΝΝΗΣ ΓΑΒΡΙΑΤΟΠΟΥΛΟΣ - Θήβα - Διάφορα - 11888.gr
The neutralizing antibody response post COVID-19 vaccination in patients with myeloma is highly dependent on the type of anti-myeloma treatment | Blood Cancer Journal
PDF) Successful treatment with lenalidomide dexamethasone for second relapse of a patient with non-secretory multiple myeloma with extramedullary liver plasmacytomas: A case report
Yannis Gavriatopoulos - Project Owner - Medtronic Diabetes Shop in Athens | LinkedIn
PDF) The Emerging Role of Immunotherapy in Intrahepatic Cholangiocarcinoma
Cureus | Metachronous Bilateral Testicular Plasmacytoma After an Initial Soft Tissue, Extramedullary Plasmacytoma
Bing Center for Waldenstrom's Macroglobulinemia - Current and novel BTK inhibitors in Waldenström's macroglobulinemia
Ioannis Lourantos - Clinical Sales Representative Peripheral & Venous - Medtronic | LinkedIn
Ioannis Lourantos - Clinical Sales Representative Peripheral & Venous - Medtronic | LinkedIn
PDF) Kinetics of Anti-SARS-CoV-2 Antibody Responses 3 Months Post Complete Vaccination with BNT162b2; A Prospective Study in 283 Health Workers
Ioannis Lourantos - Clinical Sales Representative Peripheral & Venous - Medtronic | LinkedIn
Ioannis Chochlidakis, PhD - Senior Sales Representative CRHF - Medtronic | LinkedIn
PDF) Current trends in the management and prevention of human papillomavirus (HPV) infection
Organ-specific manifestations of COVID-19 infection | Request PDF
Yannis Gavriatopoulos - Project Owner - Medtronic Diabetes Shop in Athens | LinkedIn
Ioannis Chochlidakis, PhD - Senior Sales Representative CRHF - Medtronic | LinkedIn
PDF) Predictive Factors for Neutralizing Antibody Levels Nine Months After Full Vaccination with BNT162b2: Results of a Machine Learning Analysis
Ioannis Lourantos - Clinical Sales Representative Peripheral & Venous - Medtronic | LinkedIn
Evaluation of markers of bone metabolism at baseline and at the end of... | Download Scientific Diagram
IJMS | Free Full-Text | Metabolic Disorders in Multiple Myeloma
Ioannis Chochlidakis, PhD - Senior Sales Representative CRHF - Medtronic | LinkedIn
Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy - Kastritis - - American Journal of Hematology - Wiley Online Library
